DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy

Cardiac hypertrophy (CH) is an independent risk factor for cardiovascular diseases (CVDs). Mitigating or preventing CH is the most effective strategy for the treatment of CVDs. DanHong injection (DH) is a Chinese herbal medicine preparation (CHMP) widely used in clinical treatment of several CVDs in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Zhang, Min-Yu, Guo, Fei-Fei, Wu, Hong-Wei, Yu, Yang-Yang, Wei, Jun-Ying, Wang, Shi-Feng, Zhang, Yu-Xin, Xian, Ming-Hua, Wu, Qing-Hua, Zhao, Bu-Chang, Li, Shi-You, Yang, Hong-Jun
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732736/
https://ncbi.nlm.nih.gov/pubmed/29262570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21900
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars